HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maxim Soloviev Selected Research

Maxim Soloviev Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 01/2018
1Lymphoma (Lymphomas)
01/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1Pain (Aches)
01/2012

Drug/Important Bio-Agent (IBA)

1AntibodiesIBA
01/2022
1LigandsIBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1pemigatinibIBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1parsaclisibIBA
01/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2018
1Bendamustine HydrochlorideFDA Link
01/2018
1CarrageenanIBA
01/2012
11- (7- (2- amino- 6- (4- methylpiperazin- 1- yl)pyrimidin- 4- yl)- 3,4- dihydroisoquinolin- 2(1H)- yl)- 2- cyclopentylethanoneIBA
01/2012
1Histamine (Histamine Dihydrochloride)FDA Link
01/2012
1Formaldehyde (Formol)FDA Link
01/2012

Therapy/Procedure

2Therapeutics
01/2020 - 01/2018
1Drug Tapering
01/2020